Gene Prioritization and Network Topology Analysis of Targeted Genes for Acquired Taxane Resistance by Meta-Analysis

Dongha Kim1, Young Seok Lee1, Jin Ki Kim1

  • 1Department of Biochemistry, School of Medicine, Konkuk University, Seoul, Korea.

Insights

This study identifies key genes involved in acquired taxane resistance (ATR) using network analysis of microarray data. It prioritizes candidate genes, offering new insights into cancer drug resistance mechanisms.

Area of Science:

  • Oncology
  • Bioinformatics
  • Systems Biology

Background:

  • Acquired drug resistance in cancer is a complex, multifactorial challenge.
  • Network topology-based approaches offer powerful tools for dissecting such phenomena.

Purpose of the Study:

  • To identify meta-differentially expressed genes (meta-DEGs) associated with acquired taxane resistance (ATR).
  • To prioritize these meta-DEGs using gene prioritization methods and network topology analysis.
  • To uncover novel candidate genes implicated in ATR.

Main Methods:

  • Cross-platform meta-analysis of multiple microarray datasets to identify 771 meta-DEGs.
  • Gene prioritization on co-expression and protein-protein interaction (PPI) networks.
  • Network construction and topological analysis using centrality measures.

Main Results:

  • Identified top-ranked genes in co-expression (PRSS23, ADAM9) and PPI networks (HSPA1A, ANXA1, PA2G4).
  • Uncovered several novel candidate genes associated with ATR.
  • Demonstrated the utility of integrative network analysis for identifying ATR-related genes.

Conclusions:

  • This study provides a comprehensive gene expression overview linked to ATR.
  • The proposed gene prioritization and network analysis approach effectively identifies novel ATR candidate genes.
  • Findings contribute to a deeper understanding of the molecular mechanisms underlying cancer drug resistance.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K